The Coalition for Epidemic Preparedness Innovation (CEPI) has lined up manufacturing and supply chains even though no Covid-19 vaccines are approved yet.
Today, the patent system in pharmaceuticals all too often restricts the open sharing of information, prevents further innovation by others through unjustified extensions of patents, and disincentivises real innovation.